Obalon Announces Restructuring to Streamline Operations & Cash Use
April 03, 2019 08:30 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, April 03, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Upcoming Conference Presentations
March 14, 2019 09:00 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, March 14, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable,...
Obalon Announces First Commercial Use of Navigation and Touch Products for Obalon Balloon Administration
February 27, 2019 09:00 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Feb. 27, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN) announces the first commercial use of the Obalon Navigation System™ and Touch™ Inflation Dispenser for balloon...
Obalon Announces First Commercial Shipment of its Navigation Balloon Placement System with Touch Inflation Dispenser
February 22, 2019 08:25 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Fourth Quarter and Full Year 2018 Financial Results
February 22, 2019 08:00 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Feb. 22, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Schedules Fourth Quarter and Year End 2018 Financial Results Conference Call for February 22, 2019 at 8:30 a.m. Eastern Time
February 15, 2019 09:00 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Feb. 15, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Promotion of Amy VandenBerg to Chief Clinical & Regulatory Affairs Officer
January 03, 2019 08:15 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon to Host Call to Provide Update on Commercial Strategy Post FDA Approval of the Obalon Navigation System
January 02, 2019 09:00 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Announces Promotion of Kelly Huang, Ph.D. To Chief Executive Officer
January 02, 2019 08:45 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...
Obalon Therapeutics, Inc. Announces Two Agreements To Provide Up To $30 Million of Capital
December 27, 2018 17:53 ET
|
Obalon Therapeutics, Inc.
SAN DIEGO, Dec. 27, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (Nasdaq: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled...